Fisher Andrew, General Counsel at Verona Pharma plc ($VRNA), sold shares four times on the open market over the past year, totaling about $2 million. His latest sale occurred on August 1, 2025. These transactions rank 3,531st out of 11,678 insiders in our database, trailing the average of $8.6 million across roughly 6.4 sales per insider. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Ordinary Shares | 931984 | $0.00 | 931,984.0000 | 727,223,000 | 9999.99% | 0.13% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | D | Share Options (Right to Buy) | 2240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.31% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Restricted Share Unit | 618760 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.09% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | A | Restricted Share Unit | 618760 | $0.00 | 618,760.0000 | 727,223,000 | 9999.99% | 0.09% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Restricted Share Unit | 167056 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Restricted Share Unit | 146168 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | D | Ordinary Shares | 931984 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.13% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | D | Ordinary Shares | 417903 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.06% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Ordinary Shares | 20888 | $0.00 | 427,487.0000 | 727,223,000 | 5.14% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | S | Ordinary Shares | 9584 | $13.14 | 417,903.0000 | 727,223,000 | 2.24% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Restricted Stock Units | 20888 | $0.00 | 146,168.0000 | 727,223,000 | 12.50% | 0.00% |
| July 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Ordinary Shares | 86064 | $0.00 | 446,063.0000 | 727,223,000 | 23.91% | 0.01% |
| July 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Restricted Share Units | 86064 | $0.00 | 167,056.0000 | 727,223,000 | 34.00% | 0.01% |
| July 8, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | F | Ordinary Shares | 39464 | $11.44 | 406,599.0000 | 727,223,000 | 8.85% | 0.01% |
| July 7, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | A | Restricted Share Units | 253120 | $0.00 | 253,120.0000 | 727,223,000 | 9999.99% | 0.03% |
| June 16, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Ordinary Shares | 80000 | $2.01 | 439,999.0000 | 652,311,000 | 22.22% | 0.01% |
| June 16, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Share Options (Right to Buy) | 80000 | $0.00 | 2,240,000.0000 | 652,311,000 | 3.45% | 0.01% |
| May 15, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Ordinary Shares | 80000 | $2.01 | 439,999.0000 | 652,311,000 | 22.22% | 0.01% |
| May 15, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Share Options (Right to Buy) | 80000 | $0.00 | 2,320,000.0000 | 652,311,000 | 3.33% | 0.01% |
| June 16, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | S | Ordinary Shares | 80000 | $11.53 | 359,999.0000 | 652,311,000 | 18.18% | 0.01% |
| May 15, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Share Options (Right to Buy) | 80000 | $0.00 | 2,320,000.0000 | 652,311,000 | 3.33% | 0.01% |
| May 15, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Ordinary Shares | 80000 | $2.11 | 439,999.0000 | 652,311,000 | 22.22% | 0.01% |
| May 15, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | S | Ordinary Shares | 80000 | $8.57 | 359,999.0000 | 652,311,000 | 18.18% | 0.01% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Ordinary Shares | 86064 | $0.00 | 386,065.0000 | 652,311,000 | 28.69% | 0.01% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | A | Restricted Share Units | 253120 | $0.00 | 253,120.0000 | 652,311,000 | 9999.99% | 0.04% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | S | Ordinary Shares | 26072 | $8.98 | 359,993.0000 | 652,311,000 | 6.75% | 0.00% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | M | Restricted Share Units | 86064 | $0.00 | 167,056.0000 | 652,311,000 | 34.00% | 0.01% |
| March 19, 2025 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | G | Ordinary Shares | 1 | $0.00 | 300,001.0000 | 652,311,000 | 0.00% | 0.00% |
| Oct. 30, 2024 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | A | Ordinary Shares | 300000 | $0.00 | 300,000.0000 | 648,217,000 | 9999.99% | 0.05% |
| April 1, 2024 | Verona Pharma plc | $VRNA | Fisher Andrew | General Counsel | A | Share Options (Right to Buy) | 2400000 | $0.00 | 2,400,000.0000 | 634,143,000 | 9999.99% | 0.38% |